Aurinia Pharmaceuticals
AUPH
AUPH
211 hedge funds and large institutions have $499M invested in Aurinia Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 59 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 198 → 211 (+13)
4.78% more ownership
Funds ownership: 40.37% → 45.15% (+4.8%)
4% less capital invested
Capital invested by funds: $519M → $499M (-$20.5M)
Holders
211
Holding in Top 10
2
Calls
$14.4M
Puts
$7.71M
Top Buyers
| 1 | +$13M | |
| 2 | +$6.1M | |
| 3 | +$5.85M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$5.35M |
| 5 |
Lazard Asset Management
New York
|
+$5.25M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.63M | |
| 3 | -$4.52M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.83M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2M |